Baker McKenzie advised a syndicate consisting of 12 international banks on a USD 1 billion multicurrency revolving credit facility agreement for Galderma Holding AG. Citibank, N.A., London Branch and UBS Switzerland AG acted as coordinators, bookrunners and mandated lead arrangers. UBS Switzerland AG acted as facility agent.
Galderma (SIX: GALD) is a pure-play dermatology category specialist, present in approximately 90 countries. It delivers a portfolio of premium flagship brands and services that span the full spectrum of the dermatology market through injectable aesthetics, dermatological skincare and therapeutic dermatology.
Baker McKenzie advised the lenders on all legal and tax aspects of the transaction. The team was led by Markus Wolf (Banking and Finance, Zurich) and included Andrea Bolliger (Tax, Zurich).
